Opthea Ltd has released a press release.
Opthea's Wet AMD Program to be Featured at FLORetina 2024
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Opthea
- Opthea Received A$15.9 Million R&D Tax Incentive
- Chair's Address to Shareholders
- Opthea Corporate Presentation - Oct 2024
- Opthea EURetina Symposium 2024
- Opthea Joins the S&P/ASX 300 Index
Later from Opthea
- Opthea Announces Publication in Diabetic Macular Edema
- Opthea's Corporate Presentation - Jan 2025
- Opthea Investor Day
- Opthea Completes COAST Final Week 52 Patient Visit
- Opthea Completes Drug Product PPQ Campaign
Follow Opthea into a list and get an email when it puts out news.
Follow Opthea